Sign Up to like & get
recommendations!
1
Published in 2021 at "NeuroImage"
DOI: 10.1016/j.neuroimage.2021.118248
Abstract: Purpose: 11C-UCB-J PET imaging, targeting synaptic vesicle glycoprotein 2A (SV2A), has been shown to be a useful indicator of synaptic density in Alzheimer’s disease (AD). For SV2A imaging, a decrease in apparent tracer uptake is…
read more here.
Keywords:
volume;
alzheimer disease;
ucb pet;
correction ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "EJNMMI Research"
DOI: 10.1186/s13550-020-00721-2
Abstract: Background Currently, the evidence on synaptic abnormalities in neuropsychiatric disorders—including obsessive–compulsive disorder (OCD)—is emerging. The newly established positron emission tomography (PET) ligand ((R)-1-((3-((11)C-methyl-(11)C)pyridin-4-yl)methyl)-4-(3,4,5-trifluorophenyl)pyrrolidin-2-one) ([ 11 C]UCB-J) provides the opportunity to visualize synaptic density changes in vivo,…
read more here.
Keywords:
pet;
ucb pet;
model;
autoradiography ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "EJNMMI Research"
DOI: 10.1186/s13550-021-00874-8
Abstract: [ 11 C]UCB-J is a PET radioligand that binds to the presynaptic vesicle glycoprotein 2A. Therefore, [ 11 C]UCB-J PET may serve as an in vivo marker of synaptic integrity. The main objective of this…
read more here.
Keywords:
reference;
retest repeatability;
parametric methods;
ucb pet ... See more keywords